Methylated DNA markers for plasma detection of ovarian cancer: Discovery, validation, and clinical feasibility
Lisa M. Marinelli, John B. Kisiel, Seth W. Slettedahl, Douglas W. Mahoney, Maureen A. Lemens, Vijayalakshmi Shridhar, William R. Taylor, Julie Staub, Xiaoming Cao, Patrick H. Foote, Kelli N. Burger, Calise K. Berger, Maria C. O'Connell, Karen A. Doering, Maria Giakoumopoulos, Hannah Berg, Carla J. Volkmann, Adam M. Solsrud, Hatim T. Allawi, Michael W. Kaiser, Abram Vaccaro, Catherine Albright Crawford, Cynthia Moehlenkamp, Gracie Shea, Melissa S. Deist, J. Kenneth Schoolmeester, Sarah E. Kerr, Mark E. Sherman, Jamie N. Bakkum‐Gamez
Topics & Concepts
DNA methylationMedicineOvarian cancerMethylationEpithelial ovarian cancerBisulfiteEndometrial cancerCancerPopulationSerous fluidCarcinogenesisInternal medicineOncologyMolecular biologyAndrologyBiologyDNAGeneticsGeneGene expressionEnvironmental healthEpigenetics and DNA MethylationOvarian cancer diagnosis and treatmentCancer Genomics and Diagnostics